nference

North America, Massachusetts, United States, Cambridge

Description

nference is a software company that creates transformative technologies and products in healthcare.

Investor Profile

nference has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series A, Series B rounds (top funding stages).
Majority of deals are located in United States.
Strong thematic focus on Artificial Intelligence (AI), Health Care, Health Diagnostics.

Stage Focus

Series A (50%)
Series B (50%)

Country Focus

United States (100%)

Industry Focus

Artificial Intelligence (Ai)
Health Care
Health Diagnostics
Medical Device

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does nference frequently co-invest with?

North America, California, United States, San Francisco

Co-Investments: 2

Matrix Capital Management

North America, Massachusetts, United States, Waltham

Co-Investments: 2

NTT Venture Capital

NTT Venture Capital

North America, California, United States, Menlo Park

Co-Investments: 2

Mayo Clinic Ventures

Mayo Clinic Ventures

North America, Minnesota, United States, Rochester

Co-Investments: 2

What are some of recent deals done by nference?

Cambridge, Massachusetts, United States

Anumana is an AI-driven company that develops ECG algorithms enabling early disease diagnosis and intervention.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedical Device

Series BMay 1, 2021

Amount Raised: $60,000,000

Cambridge, Massachusetts, United States

Anumana is an AI-driven company that develops ECG algorithms enabling early disease diagnosis and intervention.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedical Device

Series AApr 14, 2021

Amount Raised: $25,700,000